المساهمون: Gonzalo Sapisochin, Wei Chen Lee, Dong Jin Joo, Jae-Won Joh, Koichiro Hata, Arvinder Singh Soin, Uday Kiran Veldandi, Shuhei Kaneko, Matthias Meier, Denise Leclair, Gangadhar Sunkara, Long Bin Jeng, Joo, Dong Jin

مصطلحات موضوعية: Carcinoma, Hepatocellular* / drug therapy, Hepatocellular* / surgery, Everolimus / therapeutic use, Follow-Up Studies, Humans, Liver Neoplasms* / drug therapy, Liver Neoplasms* / surgery, Liver Transplantation, Living Donors, Retrospective Studies, Tacrolimus / therapeutic use

العلاقة: ANNALS OF TRANSPLANTATION; J00184; OAK-2022-09556; https://ir.ymlib.yonsei.ac.kr/handle/22282913/192952Test; T202300208; ANNALS OF TRANSPLANTATION, Vol.27 : e937988, 2022-11

الإتاحة: https://doi.org/10.12659/AOT.937988Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/192952Test

المساهمون: Seong-Hwi Hong, Kwang-Suk Lee, Hyun-Ji Hwang, Sung-Yul Park, Woong-Kyu Han, Young-Eun Yoon, Lee, Kwang Suk

مصطلحات موضوعية: Carcinoma, Renal Cell* / drug therapy, Renal Cell* / genetics, Renal Cell* / pathology, Cell Line, Tumor, Cell Proliferation, Everolimus / pharmacology, Everolimus / therapeutic use, Humans, Kidney Neoplasms* / drug therapy, Kidney Neoplasms* / genetics, Kidney Neoplasms* / pathology, Metformin* / pharmacology, Mitochondrial Dynamics, Neoplasm Recurrence, Local, everolimus, metformin, renal cell carcinoma

العلاقة: GENES; J03926; OAK-2022-06666; OAK-2022-06667; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191669Test; T202203281; GENES, Vol.13(7) : 1211, 2022-07

الإتاحة: https://doi.org/10.3390/genes13071211Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191669Test

المساهمون: College of Medicine, Dept. of Life Science, Sun Min Lim, Hyung Soon Park, Sangwoo Kim, Sora Kim, Siraj M. Ali, Joel R. Greenbowe, In Seok Yang, Nak-Jung Kwon, Jae Lyun Lee, Min-Hee Ryu, Jin-Hee Ahn, Jeeyun Lee, Min Goo Lee, Hyo Song Kim, Hyunki Kim, Hye Ryun Kim, Yong Wha Moon, Hyun Cheol Chung, Joo-Hang Kim, Yoon-Koo Kang, Byoung Chul Cho, Kim, Sang Woo, Kim, Hyun Ki, Kim, Hye Ryun, Kim, Hyo Song, Park, Hyung Soon, Lee, Min Goo, Lim, Sun Min, Chung, Hyun Cheol, Cho, Byoung Chul, Kim, So Ra

مصطلحات موضوعية: Adenocarcinoma/drug therapy, Adult, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Carcinoma, Renal Cell/drug therapy, Class I Phosphatidylinositol 3-Kinases, Class Ib Phosphatidylinositol 3-Kinase/genetics, Drug Resistance, Neoplasm/genetics, Everolimus/therapeutic use, Female, Head and Neck Neoplasms/drug therapy, High-Throughput Nucleotide Sequencing, Humans, Kidney Neoplasms/drug therapy, Lacrimal Apparatus/pathology, Male, Middle Aged, Mutation/genetics, Neurofibromin 1/genetics, Phosphatidylinositol 3-Kinases/genetics, Polymorphism, Single Nucleotide/genetics, Sarcoma/drug therapy, Stomach Neoplasms/drug therapy, TOR Serine-Threonine Kinases/antagonists & inhibitors, TOR Serine-Threonine Kinases/genetics, Thyroid Neoplasms/drug therapy

وصف الملف: application/pdf

العلاقة: ONCOTARGET; J02421; OAK-2016-06233; https://ir.ymlib.yonsei.ac.kr/handle/22282913/152318Test; T201604204; ONCOTARGET , Vol.7(9) : 10547-10556, 2016; 48053

الإتاحة: https://doi.org/10.18632/oncotarget.7234Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152318Test

المؤلفون: Henk M.W. Verheul, Tanja D. de Gruijl, Marco B. Polee, Paul Hamberg, Charlotte M. Huijts, Maartje Los, Inge M. Werter, Sinéad. M. Lougheed, Hans van Vliet, John B. A. G. Haanen, Helgi H. Helgason, Metin Tascilar

المساهمون: Internal medicine, Medical oncology, CCA - Cancer biology and immunology, AII - Cancer immunology, Medical oncology laboratory, Academic Medical Center

المصدر: Werter, I M, Huijts, C M, Lougheed, S M, Hamberg, P, Polee, M B, Tascilar, M, Los, M, Haanen, J B A G, Helgason, H H, Verheul, H M, de Gruijl, T D, van der Vliet, H J & Dutch WIN-O Consortium 2019, ' Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus ', Cancer Immunology, Immunotherapy, vol. 68, no. 5, pp. 787-798 . https://doi.org/10.1007/s00262-019-02313-zTest
Cancer Immunology, Immunotherapy, 68(5), 787-798. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 68, 5, pp. 787-798
Cancer immunology, immunotherapy, 68(5), 787-798. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 68, 787-798

مصطلحات موضوعية: Oncology, Male, Cancer Research, Renal Cell/drug therapy, Everolimus/therapeutic use, T-Lymphocytes, Phases of clinical research, TOR Serine-Threonine Kinases/metabolism, T-Lymphocytes, Regulatory, Tyrosine-kinase inhibitor, chemistry.chemical_compound, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Immunology and Allergy, Medicine, TOR Serine-Threonine Kinases, Middle Aged, Kidney Neoplasms, Vascular endothelial growth factor, Kidney Neoplasms/drug therapy, Treatment Outcome, Cyclophosphamide/therapeutic use, Female, Immunosuppressive Agents, medicine.drug, medicine.medical_specialty, Cyclophosphamide, medicine.drug_class, Immunology, T-Lymphocytes, Regulatory/immunology, 03 medical and health sciences, Immune system, Internal medicine, Humans, Everolimus, Carcinoma, Renal Cell, PI3K/AKT/mTOR pathway, Aged, Cell Proliferation, business.industry, Carcinoma, Interim analysis, Survival Analysis, chemistry, Carcinoma, Renal Cell/drug therapy, Immunosuppressive Agents/therapeutic use, Regulatory/immunology, business, 030215 immunology, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b177ecb737553601b0a3e3e00e7159Test
https://pubmed.ncbi.nlm.nih.gov/30756132Test